In August 18th, the novel coronavirus pneumonia diagnosis and treatment plan (trial version 8) was released. Among them, "Xuanfei Baidu formula" was added to the recommended prescriptions for the treatment of common dampness toxin stagnation of lung syndrome in TCM, while the rest continued the contents of the seventh edition; the contents of epidemiological characteristics, pathological changes, clinical characteristics, diagnostic criteria, clinical classification, differential diagnosis, case discovery and report, and treatment were revised and improved accordingly.

According to the different clinical manifestations, Chinese patent medicines Huoxiang Zhengqi Capsule, Jinhua qinggan granule, Lianhua Qingwen capsule and Shufeng Jiedu Capsule are recommended for patients in the eighth edition of diagnosis and treatment plan. Qingfei Paidu decoction is recommended for patients with mild, common, severe and some critical patients in clinical treatment period, and the phases are recommended according to different types of patients in clinical treatment period Should be the traditional Chinese medicine decoction and injection.

The eighth edition novel coronavirus pneumonia has further improved the infectious source and transmission route of new crown pneumonia, increasing "infectious in the incubation period, and infectious within 5 days after onset". Novel coronavirus specific IgM antibodies and IgG antibodies are less likely to cause a positive rate within 1 weeks, and may lead to false positives in laboratory tests, and in what cases can be diagnosed by antibody detection. In terms of diagnostic criteria, the new diagnostic criteria will be increased in terms of clinical performance. In addition, there is an increasing number of children with multiple system inflammatory syndrome (MIS-C). The positive of coronavirus specific IgM antibody is one of the diagnostic criteria of suspected cases.

It is suggested in the eighth edition of the treatment plan that drugs with potential antiviral effect should be used in the early stage of the disease, and should be mainly applied to patients with severe high-risk factors and severe tendency. The indications of glucocorticoid therapy, treatment, early rehabilitation, prevention and nursing of severe and critical cases were supplemented.

Time: 2020.8.21

Source: http://www.cntcm.com.cn/2020-08/21/content_ 79753.htm